AriM.VanderwaldeMDMPH, MBioeth, FACP

Summary

• Dr. Ari Vanderwalde is an oncologist working as the Vice President of Clinical Development for the Precision Oncology Alliance with Caris Life Sciences. He also works as Research Faculty at West Cancer Center in Memphis, TN where he served as the Director of Research from 2014 to 2021. He was the Medical Director for Precision Oncology for One Oncology from 2020-21 and was Associate Vice Chancellor for Clinical Research at University of Tennessee Health Science Center from 2014-2020. He is Senior Medical Director of George Clinical, and a Professor at the University of Memphis School of Public Health. He is affiliated with multiple hospitals in the area, including St. Jude, Baptist Memorial Hospital - Memphis, Methodist Healthcare Memphis Hospitals. He completed his training in Internal Medicine at UCLA and his fellowship in Hematology/Oncology at City of Hope Cancer Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania, his Masters of Public Health from Harvard University, a Masters in Bioethics from Penn, his BA from Harvard, and has been in practice since 2011. He specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics, and precision oncology.